Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,710,573
+$22,435,265 QoQ
Shares Held
2,322,545
+442.5% QoQ
Ownership
2.47%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 199 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Derivatives in REPL
reported options exposure · as of Jun 30, 2026CallValue
$1,503,306
CallShares
135,800
PutValue
$1,366,038
PutShares
123,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. REPL ranks #13 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in REPL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,710,573 | 2,322,545 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $1,503,306 | 135,800 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $1,366,038 | 123,400 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $1,518,525 | 198,500 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $3,275,308 | 428,145 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $211,140 | 27,600 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $550,152 | 56,600 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $1,989,684 | 204,700 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $5,679,686 | 584,330 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,427,533 | 340,700 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $351,960 | 84,000 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $2,448,111 | 584,275 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $224,818 | 24,200 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $3,128,872 | 336,800 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $809,576 | 87,145 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,582,725 | 264,895 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $3,830,234 | 316,287 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,874,236 | 262,248 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $4,826,934 | 536,326 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $1,289,371 | 157,818 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $2,052,804 | 243,512 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $1,870,695 | 80,564 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $285,403 | 16,161 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $1,281,963 | 47,131 | Shares | Defined | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||